According to Gram Research analysis, a bacterium called Haemophilus parainfluenzae is becoming increasingly resistant to multiple antibiotics, particularly in urinary tract infections. A 2026 study of 504 patients found that 30.5% of urogenital samples showed multidrug resistance, and in nearly two-thirds of symptomatic infections, this bacteria was the only pathogen detected. The resistance is spreading through mobile genetic elements shared between different bacterial strains, suggesting the problem will likely worsen without careful monitoring and appropriate antibiotic use.
Researchers in Barcelona studied a bacterium called Haemophilus parainfluenzae that’s becoming harder to treat with antibiotics. They looked at 529 samples from 504 patients between 2018 and 2022 and found that this bacteria is increasingly showing up in urinary tract and reproductive infections. About 16% of the bacteria samples were resistant to multiple antibiotics, and this resistance was especially common in urogenital infections. The bacteria is spreading resistance genes through mobile genetic elements—think of them as tiny packages of resistance instructions that bacteria can share with each other. This research suggests doctors need to pay more attention to this bacteria when treating certain infections.
Key Statistics
A 2026 laboratory study of 529 bacterial samples from 504 patients found that 16.1% of Haemophilus parainfluenzae isolates were resistant to multiple antibiotics, with resistance nearly five times more common in urogenital infections (30.5%) than respiratory infections (6.2%).
Among symptomatic urogenital infections caused by multidrug-resistant Haemophilus parainfluenzae, this bacterium was the only detectable pathogen in 65.3% of cases, according to a 2026 Barcelona hospital study of 504 patients.
A 2026 genetic analysis of 529 bacterial isolates found that 6.6% of Haemophilus parainfluenzae strains carried protective capsules, with 74% of capsulated strains showing multidrug resistance compared to 14% of non-capsulated strains.
Researchers analyzing 504 patients’ bacterial samples identified multiple resistance mechanisms in Haemophilus parainfluenzae, including β-lactamase enzymes, altered antibiotic target proteins, and efflux pumps, distributed across genetically diverse bacterial lineages with no single dominant resistant clone.
The Quick Take
- What they studied: How common is a bacterium called Haemophilus parainfluenzae in hospital infections, and how many strains are becoming resistant to antibiotics?
- Who participated: 504 patients at a large hospital in Barcelona, Spain. Researchers analyzed 529 bacterial samples collected between 2018 and 2022 from respiratory infections, urinary tract infections, and other sources.
- Key finding: About 16% of the bacteria samples were resistant to multiple antibiotics. In urinary tract infections specifically, nearly 31% of samples showed this multi-drug resistance, compared to only 6% in respiratory infections.
- What it means for you: If you have a urinary tract infection that doesn’t respond to common antibiotics, this bacteria might be responsible. Doctors may need to test for this specific organism and use different antibiotics. However, this is still a relatively uncommon cause of infections overall.
The Research Details
This was a retrospective laboratory study, meaning researchers looked back at bacterial samples that had already been collected and tested at a hospital over a five-year period. They examined 529 bacterial isolates from 504 patients, testing each one to see which antibiotics could kill it. For the bacteria that were resistant to multiple drugs, they performed genetic sequencing—essentially reading the bacteria’s DNA instruction manual—to understand exactly how the resistance worked and what genes were responsible.
The researchers categorized samples by where they came from: respiratory infections (like lung infections), urogenital infections (urinary tract and reproductive infections), and other sources. They then compared how often antibiotic resistance appeared in each category. This approach allowed them to identify patterns in which types of infections were most likely to involve resistant bacteria.
By looking at actual patient samples over several years, researchers can spot emerging problems before they become widespread. Understanding which genes cause resistance and how bacteria share these genes helps doctors predict future resistance patterns and develop better treatment strategies. The genetic analysis reveals whether resistance is spreading from a single source or appearing independently in many different bacteria—an important distinction for controlling the problem.
This study has several strengths: it examined a large number of samples (529) from a real hospital setting, used standard laboratory testing methods, and performed detailed genetic analysis on resistant strains. The main limitation is that it only looked at one hospital in one city, so results may not apply everywhere. Additionally, the study didn’t include information about patient outcomes or which antibiotics actually worked best in treating infections, so we can’t say definitively how much this resistance affects patient care.
What the Results Show
Among all 529 bacterial samples analyzed, 85 (16.1%) showed resistance to multiple antibiotics. However, this resistance was not evenly distributed. In urogenital infections (urinary tract and reproductive infections), 30.5% of samples were multidrug-resistant, compared to only 6.2% in respiratory infections. This five-fold difference suggests that this particular bacteria behaves very differently depending on where it infects the body.
Most importantly, in 65.3% of symptomatic urogenital infections caused by resistant strains, this bacteria was the only pathogen detected. This means it wasn’t just a bystander—it was likely the main cause of the infection. The resistant bacteria used multiple different mechanisms to survive antibiotics, including producing enzymes that break down antibiotics, changing the structure of proteins that antibiotics target, and pumping antibiotics out of the cell before they can cause damage.
The genetic analysis revealed something particularly concerning: the resistance genes were spread across many different bacterial strains with no single dominant clone. This suggests resistance is spreading through mobile genetic elements—essentially, bacteria are sharing resistance instructions like passing notes in a classroom. These mobile elements included integrative and conjugative elements (which can move between bacteria) and small plasmids (circular pieces of DNA that bacteria can exchange).
The researchers also found that about 6.6% of the bacterial isolates had capsules—protective outer coatings that help bacteria evade the immune system. These capsulated strains were more likely to be multidrug-resistant (74% of capsulated strains were resistant compared to 14% of non-capsulated strains). The capsular genes appeared in multiple different bacterial lineages, suggesting they’re also spreading through horizontal gene transfer rather than coming from a single source.
This research adds important detail to a growing body of evidence that Haemophilus parainfluenzae is more clinically important than previously recognized. While this bacteria has been known for decades, it was often dismissed as a harmless colonizer. This study confirms that it can be a genuine pathogen, especially in urogenital infections, and that antibiotic resistance in this species is becoming a real problem. The finding that it acts as a sexually transmitted infection-associated pathogen is relatively new and suggests doctors should screen for it in appropriate clinical contexts.
The study only examined samples from one hospital in Barcelona, so results may not apply to other regions with different antibiotic use patterns or patient populations. The researchers didn’t have clinical outcome data, so they couldn’t determine whether resistant infections were harder to treat or caused worse patient outcomes. Additionally, the study was retrospective, meaning they couldn’t control for factors like patient age, underlying health conditions, or antibiotic exposure history. Finally, the study doesn’t tell us how common this bacteria is compared to other causes of urinary tract infections, only how often resistance appears when it is present.
The Bottom Line
For healthcare providers: Consider testing for Haemophilus parainfluenzae in patients with urogenital infections, especially if initial antibiotic treatment fails. For patients: If you have a urinary tract infection that doesn’t improve with standard antibiotics, ask your doctor about testing for less common bacteria. Continue taking antibiotics exactly as prescribed and complete the full course, even if you feel better—this helps prevent resistance from developing. Moderate confidence: These recommendations are based on solid laboratory evidence but would benefit from clinical studies showing how often this bacteria causes treatment failures.
Healthcare providers treating urinary tract infections and sexually transmitted infections should be aware of this bacteria. Patients with recurrent or treatment-resistant urogenital infections may benefit from more comprehensive testing. Public health officials should monitor resistance trends in their regions. People with compromised immune systems may be at higher risk. This research is less relevant for people with respiratory infections, where this bacteria’s resistance is much less common.
If this bacteria is causing your infection, you should see improvement within 3-5 days of starting the correct antibiotic. If you don’t improve within this timeframe, contact your doctor for additional testing. Long-term, the resistance trends shown in this study suggest the problem will likely worsen over the next 5-10 years without intervention, making surveillance and appropriate antibiotic use increasingly important.
Frequently Asked Questions
What is Haemophilus parainfluenzae and why should I care about it?
Haemophilus parainfluenzae is a bacterium that causes urinary tract and reproductive infections. Recent research shows it’s becoming resistant to multiple antibiotics, making infections harder to treat. If you have recurrent urinary tract infections, your doctor should test for this specific organism.
How common is antibiotic resistance in this bacteria?
About 16% of all Haemophilus parainfluenzae samples show multidrug resistance overall, but in urinary tract infections specifically, nearly 31% are resistant. This is significantly higher than in respiratory infections, where only 6% show resistance.
Can bacteria share antibiotic resistance with each other?
Yes. This study found that Haemophilus parainfluenzae spreads resistance genes through mobile genetic elements—essentially DNA packages that bacteria can exchange. This allows resistance to spread rapidly across different bacterial strains without requiring genetic mutation.
What should I do if my urinary tract infection doesn’t respond to antibiotics?
Contact your doctor immediately. Ask for bacterial culture and sensitivity testing to identify the specific organism and which antibiotics will work. If Haemophilus parainfluenzae is found, your doctor may need to prescribe different antibiotics than typically used for urinary tract infections.
Is this bacteria sexually transmitted?
This research suggests Haemophilus parainfluenzae may be associated with sexually transmitted infection settings, though it’s not a classic STI. It appears in urogenital infections and can be transmitted sexually, but more research is needed to fully understand transmission patterns.
Want to Apply This Research?
- Log urinary tract infection symptoms (frequency, urgency, pain level on 1-10 scale) daily and note which antibiotics were prescribed and their effectiveness. Track whether symptoms resolved within 3-5 days or required a change in treatment.
- Set reminders to take antibiotics at the exact same times each day and complete the full course even after symptoms disappear. Log any side effects or lack of improvement to share with your healthcare provider.
- Over 6-12 months, track patterns in infection recurrence, which antibiotics worked, and which didn’t. Share this history with your doctor to help identify if you’re dealing with resistant strains that need different treatment approaches.
This research describes laboratory findings about bacterial antibiotic resistance patterns and does not constitute medical advice. If you have symptoms of a urinary tract infection or sexually transmitted infection, consult a healthcare provider for proper diagnosis and treatment. Do not self-diagnose or self-treat based on this information. Antibiotic resistance patterns vary by region and individual circumstances. Your doctor will determine the most appropriate testing and treatment for your specific situation based on current clinical guidelines and local resistance patterns.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.